About Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.
Industry, Sector and Symbol
Industry Drug Retailers
SectorNon-Cyclical Consumer Goods & Services
Trailing P/E Ratio21.2762430939227
Forward P/E Ratio13.49
Sales & Book Value
Annual Sales$118.21 billion
Price / Sales0.65
Cash Flow$6.74 per share
Price / Cash11.43
Book Value$26.42 per share
Price / Book2.92
Net Income$4.08 billion
Return on Equity19.15%
Return on Assets8.02%
Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions
What is Walgreens Boots Alliance's stock symbol?
Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."
How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?
Walgreens Boots Alliance announced a quarterly dividend on Friday, January 19th. Investors of record on Thursday, February 15th will be given a dividend of $0.40 per share on Monday, March 12th. This represents a $1.60 annualized dividend and a yield of 2.08%. The ex-dividend date is Wednesday, February 14th. View Walgreens Boots Alliance's Dividend History.
How will Walgreens Boots Alliance's stock buyback program work?
Walgreens Boots Alliance announced that its board has initiated a stock buyback program on Thursday, October 26th 2017, which authorizes the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued.
How were Walgreens Boots Alliance's earnings last quarter?
Walgreens Boots Alliance Inc (NASDAQ:WBA) issued its quarterly earnings results on Thursday, January, 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.27 by $0.01. The pharmacy operator had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business's quarterly revenue was up 7.9% compared to the same quarter last year. During the same period last year, the business earned $1.10 earnings per share. View Walgreens Boots Alliance's Earnings History.
When will Walgreens Boots Alliance make its next earnings announcement?
What guidance has Walgreens Boots Alliance issued on next quarter's earnings?
Walgreens Boots Alliance issued an update on its FY18 earnings guidance on Thursday, January, 4th. The company provided earnings per share guidance of $5.45-5.70 for the period, compared to the Thomson Reuters consensus estimate of $5.56.
Where is Walgreens Boots Alliance's stock going? Where will Walgreens Boots Alliance's stock price be in 2018?
20 brokerages have issued 12 month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $73.00 to $100.00. On average, they expect Walgreens Boots Alliance's share price to reach $85.89 in the next twelve months. View Analyst Ratings for Walgreens Boots Alliance.
What are Wall Street analysts saying about Walgreens Boots Alliance stock?
Here are some recent quotes from research analysts about Walgreens Boots Alliance stock:
- 1. According to Zacks Investment Research, "Walgreens Boots reported an impressive first quarter of fiscal 2018. We are encouraged by the increase in sales at the Retail Pharmacy International. Moreover, Walgreens Boots has been gaining on account of strategic tie-ups, which brought more patients to its U.S. pharmacies. We are particularly upbeat about the limited number of Rite Aid stores acquisition deal for which the company got regulatory approval recently. Also, we are upbeat about the company expanding global footprint with its decision to acquire a 40% stake in Sinopharm Holding Guoda Drugstores in China which should provide a strong impetus to Walgreens Boots’ worldwide retail pharmacy business. Accordingly, over the past three months, Walgreens Boots has been trading above the broader industry. However, declining sales at the Retail Pharmacy was a disappointment. The company faces tough competition along with currency fluctuations." (1/22/2018)
- 2. Pivotal Research analysts commented, "We believe that the asset based transaction with Rite Aid is much more beneficial for Walgreens Boots Alliance compared to the amended merger agreement from January 2017. Our quick read thru is that WBA is paying around $2.5 million per store compared to more than $4.1 million under the proposed transaction which would have included the divestiture of up to 1200 stores to Fred’s. Management appears to have a high level of confidence that it understands what is required from an FTC perspective and that the third attempt to consummate a deal with Rite Aid will pass regulatory scrutiny. The newly authorized share buyback program of $5 billion is also a significant positive for investors. The scaled down version transaction with Rite Aid will allow Walgreen to shrink the count at an accelerated rate through FY18. That said, we expect that core earnings will continue to be pressured. Quality of earnings was lacking of 3Q17, with a $0.07-$0.08 per share benefit from a lower than expected tax rate. Additionally, FIFO gross margin was down by 150 bps in the latest quarter on continued reimbursement pressures." (7/2/2017)
Are investors shorting Walgreens Boots Alliance?
Walgreens Boots Alliance saw a decrease in short interest in December. As of December 15th, there was short interest totalling 23,577,958 shares, a decrease of 5.5% from the November 30th total of 24,960,706 shares. Based on an average trading volume of 7,450,895 shares, the short-interest ratio is presently 3.2 days. Currently, 2.7% of the shares of the company are short sold.
Who are some of Walgreens Boots Alliance's key competitors?
Some companies that are related to Walgreens Boots Alliance include Altria Group (MO), Unilever (ULVR), British American Tobacco (BATS), Ambev (ABEV), Kraft Heinz (KHC), Diageo (DEO), CVS Health (CVS), Colgate-Palmolive (CL), Mondelez International (MDLZ), Estee Lauder Companies (EL), Reckitt Benckiser Group (RB), Constellation Brands (STZ), Kimberly Clark (KMB), McKesson (MCK), General Mills (GIS), SYSCO (SYY), Fomento Economico Mexicano SAB (FMX) and Tyson Foods (TSN).
Who are Walgreens Boots Alliance's key executives?
Walgreens Boots Alliance's management team includes the folowing people:
- James A. Skinner, Executive Chairman of the Board (Age 72)
- Stefano Pessina, Executive Vice Chairman and Chief Executive Officer (Age 76)
- George R. Fairweather, Executive Vice President and Global Chief Financial Officer (Age 60)
- Ornella Barra, Co-Chief Operating Officer (Age 63)
- Alexander W. Gourlay, Co-Chief Operating Officer (Age 57)
- Kathleen Wilson-Thompson, Executive Vice President, Global Chief Human Resources Officer (Age 60)
- Marco Patrick Anthony Pagni, Executive Vice President, Global Chief Administrative Officer, General Counsel (Age 55)
- Ken Murphy, Executive Vice President, Chief Commercial Officer, President of Global Brands (Age 51)
- Kimberly R. Scardino, Senior Vice President, Chief Accounting Officer, Global Controller (Age 46)
- William C. Foote, Lead Independent Director (Age 66)
Who owns Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock is owned by many different of retail and institutional investors. Top institutional investors include
ALLIANCE SANTE PARTICIPATIONS S.A.
(14.40%), Schwab Charles Investment Management Inc. (0.34%), Hexavest Inc. (0.14%), Bank of Montreal Can (0.13%), National Pension Service (0.08%) and Chevy Chase Trust Holdings Inc. (0.08%). Company insiders that own Walgreens Boots Alliance stock include Barry Rosenstein, George Rollo Fairweather, Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.
Who sold Walgreens Boots Alliance stock? Who is selling Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Acadian Asset Management LLC, Chevy Chase Trust Holdings Inc., Strs Ohio, Cim LLC, Oakbrook Investments LLC, RNC Capital Management LLC and Exxonmobil Investment Management Inc. TX. View Insider Buying and Selling for Walgreens Boots Alliance.
Who bought Walgreens Boots Alliance stock? Who is buying Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Cardinal Capital Management Inc., Chesley Taft & Associates LLC, MU Investments Co. Ltd., Alta Capital Management LLC, State of Alaska Department of Revenue, Gateway Investment Advisers LLC and National Pension Service. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.
How do I buy Walgreens Boots Alliance stock?
Shares of Walgreens Boots Alliance can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Walgreens Boots Alliance's stock price today?
One share of Walgreens Boots Alliance stock can currently be purchased for approximately $77.02.
How big of a company is Walgreens Boots Alliance?
Walgreens Boots Alliance has a market capitalization of $76.30 billion and generates $118.21 billion in revenue each year. The pharmacy operator earns $4.08 billion in net income (profit) each year or $3.62 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.
How can I contact Walgreens Boots Alliance?
Walgreens Boots Alliance's mailing address is 108 Wilmot Rd, DEERFIELD, IL 60015-5145, United States. The pharmacy operator can be reached via phone at +1-847-3152500 or via email at [email protected]
MarketBeat Community Rating for Walgreens Boots Alliance (WBA)MarketBeat's community ratings are surveys of what our community members think about Walgreens Boots Alliance and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Walgreens Boots Alliance (NASDAQ:WBA) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.60||2.60||2.70||2.81|
|Ratings Breakdown: ||0 Sell Rating(s)|
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
8 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$85.89||$86.39||$87.65||$90.21|
|Price Target Upside: ||16.98% upside||17.94% upside||26.37% upside||13.94% upside|
Walgreens Boots Alliance (NASDAQ:WBA) Consensus Price Target History
Walgreens Boots Alliance (NASDAQ:WBA) Analyst Ratings History
(Data available from 1/24/2016 forward)
Walgreens Boots Alliance (NASDAQ:WBA) Earnings History and Estimates Chart
Walgreens Boots Alliance (NASDAQ WBA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|1/4/2018||Q1 2018||$1.27||$1.28||$30.39 billion||$30.74 billion||View||Listen|
|10/25/2017||Q4 2017||$1.21||$1.31||$29.93 billion||$30.15 billion||View||N/A|
|6/29/2017||Q3 2017||$1.30||$1.33||$29.72 billion||$30.12 billion||View||N/A|
|4/5/2017||Q2 2017||$1.36||$1.36||$30.17 billion||$29.45 billion||View||Listen|
|1/5/2017||Q117||$1.09||$1.10||$29.37 billion||$28.50 billion||View||Listen|
|10/20/2016||Q416||$0.99||$1.07||$29.06 billion||$28.60 billion||View||Listen|
|7/6/2016||Q316||$1.14||$1.18||$29.93 billion||$29.50 billion||View||N/A|
|4/5/2016||Q216||$1.28||$1.31||$30.72 billion||$30.18 billion||View||N/A|
|1/7/2016||Q116||$0.96||$1.03||$29.24 billion||$29.00 billion||View||N/A|
|10/28/2015||Q415||$0.81||$0.88||$28.45 billion||$28.50 billion||View||Listen|
|7/9/2015||Q315||$0.87||$1.02||$30.28 billion||$28.80 billion||View||N/A|
|4/9/2015||Q215||$0.94||$1.18||$27.27 billion||$26.60 billion||View||N/A|
|12/23/2014||Q115||$0.75||$0.81||$19.43 billion||$19.55 billion||View||N/A|
|9/30/2014||Q414||$0.74||$0.74||$19.02 billion||$19.06 billion||View||N/A|
|6/24/2014||Q314||$0.94||$0.91||$19.33 billion||$19.40 billion||View||N/A|
|3/25/2014||Q214||$0.93||$0.91||$19.61 billion||$19.60 billion||View||N/A|
|12/20/2013||Q1||$0.72||$0.72||$17.98 billion||$18.30 billion||View||Listen|
|10/1/2013||Q413||$0.72||$0.73||$17.95 billion||$17.90 billion||View||N/A|
|6/25/2013||Q3 2013||$0.91||$0.85||$18.44 billion||$18.30 billion||View||N/A|
|3/19/2013||Q2 2013||$0.94||$0.96||$18.72 billion||$18.65 billion||View||N/A|
|12/21/2012||Q1 2013||$0.70||$0.58||$17.50 billion||$17.32 billion||View||N/A|
|9/28/2012||Q412||$0.56||$0.63||$17.16 billion||$17.10 billion||View||N/A|
|12/22/2010||$0.54||$0.62||$17.31 billion||$17.34 billion||View||N/A|
Walgreens Boots Alliance (NASDAQ:WBA) Earnings Estimates
2018 EPS Consensus Estimate: $4.58
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Walgreens Boots Alliance (NASDAQ:WBA) Dividend Information
|Payout Ratio:||44.20% (Trailing 12 Months of Earnings) |
28.02% (Based on This Year's Estimates)
25.36% (Based on Next Year's Estimates)
Walgreens Boots Alliance (NASDAQ:WBA) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Walgreens Boots Alliance (NASDAQ WBA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 14.80%
Institutional Ownership Percentage: 61.15%
Walgreens Boots Alliance (NASDAQ WBA) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/15/2018||Stefano Pessina||Insider||Buy||98,858||$76.07||$7,520,128.06|| |
|11/2/2017||William C Foote||Director||Sell||2,736||$67.37||$184,324.32||16,415|| |
|10/26/2017||John Anthony Lederer||Director||Buy||20,000||$67.00||$1,340,000.00||50,000|| |
|7/25/2017||William C Foote||Director||Sell||2,736||$79.79||$218,305.44||19,151|| |
|5/3/2017||William C Foote||Director||Sell||2,736||$85.89||$234,995.04||21,887|| |
|2/7/2017||Ornella Barra||COO||Buy||124,000||$80.93||$10,035,320.00||1,690,336|| |
|2/2/2017||Janice M Babiak||Director||Buy||600||$80.68||$48,408.00||600|| |
|11/28/2016||Kathleen Wilson-Thompson||EVP||Sell||5,700||$85.05||$484,785.00|| |
|11/4/2016||Stefano Pessina||Insider||Buy||2,000,000||$81.41||$162,820,000.00|| |
|11/2/2016||William C Foote||Director||Sell||2,067||$81.30||$168,047.10||24,623|| |
|9/8/2016||Kathleen Wilson-Thompson||EVP||Sell||23,996||$85.00||$2,039,660.00|| |
|7/26/2016||William C Foote||Director||Sell||2,067||$81.35||$168,150.45||26,690|| |
|7/14/2016||Kathleen Wilson-Thompson||EVP||Sell||29,695||$83.00||$2,464,685.00|| |
|7/8/2016||Kathleen Wilson-Thompson||EVP||Sell||29,695||$81.03||$2,406,185.85|| |
|6/10/2016||Kathleen Wilson-Thompson||EVP||Sell||29,603||$83.13||$2,460,897.39||128,037|| |
|5/16/2016||Barry Rosenstein||Director||Sell||6,000,000||$77.29||$463,740,000.00|| |
|4/21/2016||William C Foote||Director||Sell||2,066||$80.99||$167,325.34||28,757|| |
|4/15/2016||George Rollo Fairweather||CFO||Sell||50,000||$81.52||$4,076,000.00||13,867|| |
|3/17/2016||Kathleen Wilson-Thompson||EVP||Sell||13,728||$83.01||$1,139,561.28||112,054|| |
|2/18/2016||Barry Rosenstein||Director||Sell||1,720,900||$76.96||$132,440,464.00|| |
|1/12/2016||John Anthony Lederer||Director||Buy||10,000||$81.00||$810,000.00||30,000|| |
|11/20/2015||Barry Rosenstein||Director||Sell||1,452,470||$82.37||$119,639,953.90|| |
|11/4/2015||William C Foote||Director||Sell||3,500||$88.36||$309,260.00||30,823|| |
|11/2/2015||John Anthony Lederer||Director||Buy||10,000||$84.88||$848,800.00||20,000|| |
|7/16/2015||William C Foote||Director||Sell||3,500||$94.95||$332,325.00|| |
|4/29/2015||John Anthony Lederer||Director||Buy||10,000||$85.00||$850,000.00|| |
|1/29/2015||Thomas J Sabatino Jr||CAO||Sell||36,477||$73.76||$2,690,543.52|| |
|12/15/2014||Kathleen Wilson-Thompson||SVP||Sell||40,769||$73.75||$3,006,713.75|| |
|11/7/2014||Kermit R Crawford||EVP||Sell||126,441||$66.32||$8,385,567.12|| |
|11/3/2014||Sona Chawla||CMO||Sell||21,200||$65.00||$1,378,000.00|| |
|10/14/2014||Barry Rosenstein||Director||Buy||1,250,000||$61.86||$77,325,000.00|| |
|9/19/2014||Sona Chawla||CMO||Sell||9,443||$63.44||$599,063.92|| |
|8/11/2014||Mia M Scholz||SVP||Sell||81,015||$61.93||$5,017,258.95|| |
|8/7/2014||Gregory D Wasson||CEO||Sell||24,279||$60.06||$1,458,196.74|| |
|4/16/2014||Robert Zimmerman||SVP||Sell||26,201||$66.07||$1,731,100.07||53,974|| |
|4/15/2014||Kermit Crawford||Insider||Sell||74,287||$66.01||$4,903,684.87||90,166|| |
|1/24/2014||Graham Atkinson||SVP||Sell||24,304||$58.05||$1,410,847.20||48,220|| |
|1/16/2014||Robert Zimmerman||SVP||Sell||10,426||$60.00||$625,560.00||53,907|| |
|1/13/2014||Timothy Theriault||SVP||Sell||64,815||$60.50||$3,921,307.50||112,839|| |
|7/12/2013||Stefano Pessina||Director||Buy||34,439||$45.77||$1,576,273.03|| |
|5/21/2013||Kermit R Crawford||Insider||Sell||10,000||$50.03||$500,300.00|| |
|4/19/2013||Stefano Pessina||Director||Buy||83,299||$48.62||$4,049,997.38|| |
Walgreens Boots Alliance (NASDAQ WBA) News Headlines
Walgreens Boots Alliance (NASDAQ:WBA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Walgreens Boots Alliance (NASDAQ:WBA) Income Statement, Balance Sheet and Cash Flow Statement
Walgreens Boots Alliance (NASDAQ WBA) Stock Chart for Wednesday, January, 24, 2018